MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
ATAGI advice gives governments a chance to 'walk back' their missteps on AZ
July 24, 2021 - - Latest News -
Immutep announces completion of share purchase plan
July 23, 2021 - - Australian Biotech -
BCAL Diagnostics debuts on the Australian Securities Exchange
July 23, 2021 - - Australian Biotech -
Technovalia starts phase one trial of its COVID-19 vaccine candidate
July 23, 2021 - - Australian Biotech -
Bupa Dental partners on trial to assess the impact of head knocks
July 23, 2021 - - Other Health -
Medibank confirms support for customers living through lockdown
July 23, 2021 - - Other Health -
No need for ATAGI to change its advice with states already adjusting for 'balance of risk'
July 23, 2021 - - Latest News